SGBHD

0.295

+0.04 (+15.7%)

TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS SUPERGENICS BERHAD (SUPERGENICS OR COMPANY) PROPOSED SUBSCRIPTION OF 242,500 NEW ORDINARY SHARES IN HOPE STEMCELL SDN BHD BY SUPERGENICS LIFE SCIENCE SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY, REPRESENTING 19.40% EQUITY INTEREST IN HOPE STEMCELL SDN BHD FOR A TOTAL CASH CONSIDERATION OF RM242,500

SUPERGENICS BERHAD

Type Announcement
Subject TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
SUPERGENICS BERHAD (SUPERGENICS OR COMPANY)

PROPOSED SUBSCRIPTION OF 242,500 NEW ORDINARY SHARES IN HOPE STEMCELL SDN BHD BY SUPERGENICS LIFE SCIENCE SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY, REPRESENTING 19.40% EQUITY INTEREST IN HOPE STEMCELL SDN BHD FOR A TOTAL CASH CONSIDERATION OF RM242,500

On behalf of the Board of Directors of Supergenics, Thinkat Advisory Sdn Bhd wishes to announce that Supergenics Life Science Sdn Bhd ("SLSSB"), a wholly-owned subsidiary of Supergenics, had on 30 August 2021 entered into a share subscription agreement ("SSA") with Hope Stemcell Sdn Bhd ("Hope") for the proposed subscription of 242,500 new ordinary shares in Hope by SLSSB, representing 19.40% equity interest in Hope on an enlarged basis for a total cash consideration of RM242,500 ("Proposed Subscription"). The existing equity interest of SLSSB in Hope is 11.91%. 

 

In addition, the shareholders of Hope (including SLSSB) executed a further supplemental agreement on 30 August 2021 ("Supplemental Shareholders Agreement 2")to further amend the provision of the principal shareholders agreement and first supplemental agreement.  

 

Please refer to the attachment for further details on the Proposed Subscription and Supplemental Shareholders Agreement 2.

 

This announcement is dated 30 August 2021.




Please refer attachment below.



Announcement Info

Company Name SUPERGENICS BERHAD
Stock Name SGBHD
Date Announced 30 Aug 2021
Category General Announcement for PLC
Reference Number GA1-30082021-00148